Journal article icon

Journal article

Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trial

Abstract:
Introduction: Many people living with dementia experience sleep disturbance and there are no known effective treatments. Non-pharmacological treatment options should be the first-line sleep management. For family carers, relatives’ sleep disturbance leads to interruption of their sleep, low mood and breakdown of care. Our team developed and delivered DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives), a multimodal non-pharmacological intervention, showing it to be feasible and acceptable. The aim of this randomised controlled trial is to establish whether DREAMS START is clinically cost-effective in reducing sleep disturbances in people living with dementia living at home compared with usual care. // Methods and analysis: We will recruit 370 participant dyads (people living with dementia and family carers) from memory services, community mental health teams and the Join Dementia Research Website in England. Those meeting inclusion criteria will be randomised (1:1) either to DREAMS START or to usual treatment. DREAMS START is a six-session (1 hour/session), manualised intervention delivered every 1–2 weeks by supervised, non-clinically trained graduates. Outcomes will be collected at baseline, 4 months and 8 months with the primary outcome being the Sleep Disorders Inventory score at 8 months. Secondary outcomes for the person with dementia (all proxy) include quality of life, daytime sleepiness, neuropsychiatric symptoms and cost-effectiveness. Secondary outcomes for the family carer include quality of life, sleep disturbance, mood, burden and service use and caring/work activity. Analyses will be intention-to-treat and we will conduct a process evaluation. // Ethics and dissemination: London—Camden & Kings Cross Ethics Committee (20/LO/0894) approved the study. We will disseminate our findings in high-impact peer-reviewed journals and at national and international conferences. This research has the potential to improve sleep and quality of life for people living with dementia and their carers, in a feasible and scalable intervention. // Trial registration number: ISRCTN13072268
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/bmjopen-2023-075273
Publication website:
https://discovery.ucl.ac.uk/10186626/1/e075273.full.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0479-6950
More by this author
Role:
Author
ORCID:
0000-0003-4196-6410
More by this author
Role:
Author
ORCID:
0000-0002-7272-2462
More by this author
Role:
Author
ORCID:
0000-0002-8083-7649
More by this author
Role:
Author
ORCID:
0000-0001-5762-762X


More from this funder
Funder identifier:
10.13039/501100000664
Grant:
NIHR HTA 128761


Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
14
Issue:
2
Pages:
e075273-e075273
Publication date:
2024-02-01
DOI:
EISSN:
2044-6055
ISSN:
2044-6055


Language:
English
Keywords:
Pubs id:
1611861
Local pid:
pubs:1611861
Source identifiers:
W4391481317
Deposit date:
2026-06-05
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP